Evidence map›Paper›PMID 42443620›Full record

ArticlePsychopharmacology2026

Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.

Helena D Aicher, Joëlle Dornbierer, Luzia Caflisch, Dila Suay, Michael J Mueller, Hans-Peter Landolt, Boris B Quednow, Milan Scheidegger, Dario Dornbierer

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Helena D AicherPsychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland. helena.aicher@uzh.ch.ORCID http://orcid.org/0000-0001-5915-7086
Joëlle DornbiererPsychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland. joellealine.dornbierer@uzh.ch.ORCID http://orcid.org/0009-0006-6902-7182
Luzia CaflischPsychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.ORCID http://orcid.org/0009-0004-6813-8986
Dila SuayPsychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-5268-9992
Michael J MuellerPsychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-9774-9805
Hans-Peter LandoltNeuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-0887-9403
Boris B QuednowExperimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-7933-2865
Milan ScheideggerPsychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-1313-2208
Dario DornbiererPsychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-9946-2069

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RATIONALE AND

objectivesNegative self-referential emotions such as embarrassment and shame play a key role in the psychopathology of psychiatric disorders but are often insufficiently addressed by standard treatments. Psychedelics such as ayahuasca - an Amazonian plant decoction containing the psychedelic N,N-dimethyltryptamine (DMT) and harmala alkaloids, have been proposed to positively modulate self-referential processing. The aim of this study was to investigate the effects of an ayahuasca-inspired harmine+DMT formulation and harmine on embarrassment and shame.

methodsIn this randomized, double-blind, placebo-controlled crossover trial (N = 28 healthy males), the effects of combined 100mg harmine and 100mg DMT (HAR/DMT), harmine alone (HAR), against placebo (PLA) on self-referential processing was investigated using a karaoke paradigm, where participants listened to recordings of their own singing (Self = S) and control vocal tracks (other bad = OB; other good = OG) and rated emotional responses. Acute emotions were assessed with visual analogue scales (items: pleasant, unpleasant, embarrassing, funny, and objective quality) and the Experiential Shame Scale (ESS).

resultsHAR/DMT compared to placebo significantly reduced embarrassment in the Self condition (EMM=-16.83, p=.001), but not in the two other conditions (OB: EMM=-4.38, p=.628; OG: EMM= 2.14, p=.894). HAR/DMT-HAR or HAR-PLA contrasts for embarrassment were not significant for any condition. HAR/DMT compared to placebo reduced ESS global score (F(df)= 4.26(2, 54); p=.019) and ESS emotional subscale (F(df)=5.11(2, 54); p=.009), while harmine alone showed no significant effects.

conclusionsThese findings suggest that HAR/DMT acutely modulates negative self-referential emotions and may, thus, offer a promising therapeutic approach, which should be further investigated in clinical populations.

Indexed as

EmbarrassmentHallucinogensHarmineN,N-dimethyltryptamineSelf-conceptShameSocial cognition

Identifiers

PMID42443620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.